Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese Patients

Saitama Medical University

Status

Unknown

Conditions

Hypertension

Treatments

Drug: Candesartan

Drug: Telmisartan

Study type

Interventional

Funder types

Other

Identifiers

NCT00288717

UMIN-CTR-C000000324

FUJIYAMA-Study

Details and patient eligibility

About

To investigate the effects of Candesartan and Telmisartan on the home blood pressure, glucose and lipid-metabolism in the hypertensive patients with the accumulation of visceral fat by the newly developed Tele-medicine system

Full description

A randomized, comparative study of the effects of Candesartan and Telmisartan on the home blood pressure, glucose and lipid metabolism in the hypertensive patients with the accumulation of visceral fat by the central registration system

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Circumference at waist: male ≧85 cm, female ≧90 cm
Hypertensive patient with untreated hypertension, and casual blood pressure of systole ≧140 mmHg, or diastole ≧90 mmHg
Hypertensive patient with hypertension under treatment, and casual blood pressure of systole ≧130 mmHg, or diastole ≧85 mmHg

Exclusion criteria

Significant hypertensive patient with diastolic blood pressure ≧120 mmHg
Malignant hypertensive patient
Patient with a contraindication to the study drugs (hypersensitivity, significant hepatic diseases, pregnant woman)
Patient with urinary protein (qualitative) ＋～＋＋
Patient with familial hyperlipidemia
Other patients judged as ineligible for the study